Erika Carmel-Tech Ltd (TLV:ERKA)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
50.50
+5.40 (11.97%)
Apr 28, 2026, 10:17 AM IDT
9.78%
Market Cap 18.79M
Revenue (ttm) 37.34M
Net Income (ttm) -5.85M
Shares Out 41.67M
EPS (ttm) -0.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 25
Average Volume 38,115
Open 45.10
Previous Close 45.10
Day's Range 45.10 - 50.50
52-Week Range 37.50 - 77.50
Beta 1.19
RSI 41.28
Earnings Date May 5, 2026

About Erika Carmel-Tech

Erika Carmel-Tech Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It provides B-Cure Laser Classic, a non-invasive and safe medical device for the treatment of chronic and acute pain for home use; and B-Cure Laser Pro, a clinically proven, non-invasive and safe medical device for treatment of both acute and chronic conditions. The company treats achilles tendon inflammation, burns, carpal tunnel syndrome, finger joint pain, fibromyalgia, hip pain, post-dental treatment, lower ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2007
Employees 45
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol ERKA
Full Company Profile

Financial Performance

In 2025, Erika Carmel-Tech's revenue was 37.34 million, a decrease of -1.64% compared to the previous year's 37.96 million. Losses were -5.85 million, -38.19% less than in 2024.

Financial Statements

News

There is no news available yet.